Study to Evaluate the Effect on Parameters of Systemic Inflammation and Disease Outcomes and Safety of RPH-104 in Subjects With Acute ST-elevation Myocardial Infarction
Clinical trial NCT04463251 · COMPLETED
Trial details
- NCT number
- NCT04463251
- Sponsor
- R-Pharm Overseas, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-07
- Primary completion
- 2021-11-03
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.